3 results
The present study will investigate whether implementation of the Hemostasis Management System (HMS) in cardiothoracic surgery will result in higher doses of heparin and lower doses of protamine, thereby leading to a less impaired postoperative…
The main objective of this trial is to assess whether treatment adaptation based on a very early FDG-PET results in improved efficacy while minimizing treatment toxicity in advanced stage HL patients treated with BV-containing regimens, BrAVD and…
To evaluate the safety of a new scaffold platform in native coronary arteries that includes incorporation of a deformable expansion technology and an enhanced scaffold material that is a polycarbonate co-polymer of tyrosine analogs. This will be…